Expertise in
4
conditions

Hongwei Z. Xu

324 Jingwu Road, 
Jinan, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
324 Jingwu Road, 
Jinan, CN 

Overview

Hongwei Xu practices practicing medicine in Jinan, China.

Xu is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Acute Pancreatitis, Hereditary Pancreatitis, Chronic Erosive Gastritis, Endoscopy, and Colonoscopy.

They are actively involved in clinical research, co-authoring 152 peer reviewed articles and participating in 4 clinical trials.

Locations

324 Jingwu Road, Jinan, 250021, China
Other Locations
2901 Beidi Road, Minhang, 201106, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Single-arm, Pivotal Registration Phase II Study of the Efficacy and Safety of APG-2575 Monotherapy in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A Single-arm, Pivotal Registration Phase II Study of the Efficacy and Safety of APG-2575 Monotherapy in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Enrollment Status: Recruiting
Publish Date: March 27, 2026
Intervention Type: Drug
Study Drug: APG2575
Study Phase: Phase 2
A Multi-center, Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of HMPL-689 in Patients With Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
A Multi-center, Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of HMPL-689 in Patients With Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug
Study Drug: HMPL-689
Study Phase: Phase 2
A Prospective, Multicenter, Single-arm, Observational Study to Evaluate the Safety and Effectiveness of Vedolizumab in Real-World Clinical Practice in China
A Prospective, Multicenter, Single-arm, Observational Study to Evaluate the Safety and Effectiveness of Vedolizumab in Real-World Clinical Practice in China
Enrollment Status: Completed
Publish Date: July 22, 2024
A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Clinical Study on the Effecacy and Safety of Different Dosing Regimens of Hemay007 in Patients With Active Ulcerative Colitis
A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Clinical Study on the Effecacy and Safety of Different Dosing Regimens of Hemay007 in Patients With Active Ulcerative Colitis
Enrollment Status: Terminated
Publish Date: March 01, 2024
Intervention Type: Drug
Study Drug: Hemay007
Study Phase: Phase 2
View 3 Less Clinical Trials

152 Total Publications

Ultrathin endoscope-assisted endotracheal intubation in the prone position for endoscopic retrograde cholangiopancreatography: a standardized protocol.
Ultrathin endoscope-assisted endotracheal intubation in the prone position for endoscopic retrograde cholangiopancreatography: a standardized protocol.
Journal: Endoscopy
Published: March 09, 2026

Frequently Asked Questions about Hongwei Z. Xu

Is Hongwei Z. Xu a top-rated expert for Acute Pancreatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Hongwei Z. Xu is classified as an Advanced expert for Acute Pancreatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hongwei Z. Xu participate in research or clinical trials?

Yes. Hongwei Z. Xu has published 152 articles and abstracts on conditions like Acute Pancreatitis. You can view a list of Hongwei Z. Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xu's expertise for a condition
ConditionClose
      View All 40 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile